Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003026334 | SCV003329217 | pathogenic | Achondrogenesis, type IB; Atelosteogenesis type II; Multiple epiphyseal dysplasia type 4; Diastrophic dysplasia | 2022-09-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLC26A2-related conditions. This sequence change creates a premature translational stop signal (p.Lys72*) in the SLC26A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A2 are known to be pathogenic (PMID: 7923357, 10482955, 11241838). This variant is not present in population databases (gnomAD no frequency). |
Baylor Genetics | RCV004572579 | SCV005056812 | likely pathogenic | Achondrogenesis, type IB | 2024-03-23 | criteria provided, single submitter | clinical testing |